失代偿期肝硬化患者适当与潜在不适当用药情况
基于2010-2015年美国大型全国理赔数据库,分析12,621例失代偿期肝硬化患者的完整用药谱及与适当和潜在不适当用药相关的因素。腹水最常见(86.5%),但仅55.8%填写利尿剂处方;潜在不适当用药常见,53.2%填写阿片类。疾病严重度标志与更适当用药相关,但与更少不适当用药不一致相关。
要点
- 失代偿期肝硬化患者未按推荐频率和时长填写适应症药物,且常填写潜在有害药物。
- 腹水患者中55.8%填写利尿剂,肝性脑病患者中32.4%和63.3%分别填写利福昔明和乳果糖。
- 潜在不适当用药常见:53.2%填写阿片类,46.0%质子泵抑制剂,14.2%苯二氮䓬类,10.1%非甾体抗炎药。
核心结论
- 失代偿期肝硬化患者未按推荐频率和时长填写适应症药物,且常填写潜在有害药物。
- 未来步骤包括整合药房记录与医疗记录以获得完整用药清单,并在每次就诊时对患者进行用药咨询。
研究设计与样本
- 研究利用2010-2015年大型全国理赔数据库,纳入12,621例失代偿期肝硬化患者,分析其完整用药谱及与适当和潜在不适当用药相关的因素。
- 适当和潜在不适当用药依据临床指南和现有文献确定。
- 总药物供应天数从药房数据计算,并除以每次失代偿的随访期。
主要发现
- 腹水最常见(86.5%),其次为肝性脑病(37.8%)、静脉曲张出血(17.5%)、肝肾综合征(6.3%)和自发性细菌性腹膜炎(6.1%)。
- 腹水患者中55.8%填写利尿剂;肝性脑病患者中32.4%填写利福昔明,63.3%填写乳果糖。
- 静脉曲张出血后60.3%患者填写非选择性β受体阻滞剂;自发性细菌性腹膜炎发作后48.0%患者填写抗生素用于预防。
- 少数患者(4.5%-17.3%)拥有覆盖超过50%随访天数的足够药物。
- 潜在不适当用药常见:53.2%填写阿片类,46.0%质子泵抑制剂,14.2%苯二氮䓬类,10.1%非甾体抗炎药。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Patients with decompensated cirrhosis are prescribed numerous medications. Data are limited as to whether patients are receiving medications they need and avoiding those they do not. We examined a large national claims database (2010-2015) to characterize the complete medication profile as well as the factors associated with appropriate and potentially inappropriate medication use in 12,621 patients with decompensated cirrhosis. APPROACH AND RESULTS: Clinical guidelines and existing literature were used to determine appropriate and potentially inappropriate medications in decompensated cirrhosis. The total medication days' supply was calculated from pharmacy data and divided by the follow-up period for each decompensation. Ascites was the most common (86.5%), followed by hepatic encephalopathy (HE; 37.8%), variceal bleeding (VB; 17.5%), hepatorenal syndrome (6.3%), and spontaneous bacterial peritonitis (SBP; 6.1%). For patients with ascites, 55.8% filled a diuretic. For patients with HE, 32.4% and 63.3% filled rifaximin and lactulose, respectively. After VB, 60.3% of patients filled a nonselective beta blocker, and after an episode of SBP, 48.0% of patients filled an antibiotic for prophylaxis. The minority (4.5%-17.3%) had enough medication to cover >50% follow-up days. Potentially inappropriate medication use was common: 53.2% filled an opiate, 46.0% proton pump inhibitors, 14.2% benzodiazepines, and 10.1% nonsteroidal anti-inflammatory drugs. Disease severity markers were associated with more appropriate mediation use but not consistently associated with less inappropriate medication use. CONCLUSIONS: Patients with decompensated cirrhosis are not filling indicated medications as often or as long as is recommended and are also filling medications that are potentially harmful. Future steps include integrating pharmacy records with medical records to obtain a complete medication list and counseling on medication use with patients at each visit.
引用
- Thomson MJ, Lok ASF, Tapper EB, et al. Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis. Hepatology. 2021. PMID: 32911564. doi:10.1002/hep.31548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。